Interim Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2022	Sep. 30, 2021
Current assets
Cash and cash equivalents	$ 153,342,556	$ 152,107,745
Incentive and tax receivables	6,468,987	9,136,831
Prepaid expenses and other current assets	464,605	371,914
Total assets	160,276,148	161,616,490
Current Liabilities
Accounts payable	2,631,888	4,739,781
Accrued liabilities (Note 4)	4,995,388	5,614,774
Deferred grant income	443,831	443,831
Total liabilities	8,071,107	10,798,386
Stockholders' equity
(September 30, 2021 - 75,918,465)	77,163	75,920
Additional paid-in capital	371,437,616	348,328,048
Share proceeds receivable	(403,696)
Accumulated deficit	(218,906,042)	(197,585,864)
Total stockholders' equity	152,205,041	150,818,104
Total liabilities and stockholders' equity	$ 160,276,148	$ 161,616,490

No definition available.

Name:	avxl_ShareProceedsReceivable
Namespace Prefix:	avxl_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).